Hospital admissions related to acute exacerbations of chronic obstructive pulmonary disease in France, 1998-2007.

[1]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[2]  C. Fuhrman,et al.  L’asthme en France : synthèse des données épidémiologiques descriptives , 2010 .

[3]  N. Roche,et al.  Caractéristiques et prise en charge des exacerbations aiguës de BPCO hospitalisées. Étude EABPCO–CPHG du Collège des pneumologues des hôpitaux généraux , 2010 .

[4]  Cristóbal Esteban,et al.  Impact of hospitalisations for exacerbations of COPD on health-related quality of life. , 2009, Respiratory medicine.

[5]  A. Fagot-Campagna,et al.  Incidence and characteristics of lower limb amputations in people with diabetes , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[6]  T. MacDonald,et al.  Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD , 2009, Thorax.

[7]  N. Roche,et al.  Predictors of outcomes in COPD exacerbation cases presenting to the emergency department , 2008, European Respiratory Journal.

[8]  N. Bartolomeo,et al.  Hospitalisation for COPD in Puglia: the role of hospital discharge database to estimate prevalence and incidence. , 2008, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[9]  N. Johnston.  The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations. , 2007, Proceedings of the American Thoracic Society.

[10]  A. Lowe,et al.  A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. , 2007, Respiratory medicine.

[11]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[12]  D. Mannino,et al.  Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.

[13]  J. D. de Miguel-Yanes,et al.  Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. , 2007, The American journal of emergency medicine.

[14]  C. Fuhrman,et al.  Evolution des hospitalisations pour asthme en France métropolitaine, 1998-2002 , 2007 .

[15]  L. Pascal,et al.  [Trends in hospital admissions for asthma in France, 1998-2002]. , 2007, Revue des maladies respiratoires.

[16]  P. Frith,et al.  Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993–2003 , 2007, The Medical journal of Australia.

[17]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[18]  M. Decramer,et al.  Integrated care prevents hospitalisations for exacerbations in COPD patients , 2006, European Respiratory Journal.

[19]  D. Eilstein,et al.  Deaths from chronic obstructive pulmonary disease in France, 1979–2002: a multiple cause analysis , 2006, Thorax.

[20]  S. Johnston,et al.  Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. , 2006, American journal of respiratory and critical care medicine.

[21]  K. R. Chapman,et al.  Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[22]  R. Dales,et al.  Changing age-pattern of hospitalisation risk of chronic obstructive pulmonary disease in men and women in Canada. , 2006, Age and ageing.

[23]  Fernando Holguin,et al.  Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. , 2005, Chest.

[24]  R. Dales,et al.  Changing age-pattern of hospitalisation risk of chronic obstructive pulmonary disease in men and women in Canada , 2005 .

[25]  A. Tonnel,et al.  Impact économique de la BPCO en France : étude SCOPE , 2005 .

[26]  I. Durand-zaleski,et al.  [Economic burden of COPD: the SCOPE study]. , 2005, Revue des maladies respiratoires.

[27]  I. Durand-zaleski,et al.  The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[28]  T. Seemungal,et al.  Longitudinal changes in the nature, severity and frequency of COPD exacerbations , 2003, European Respiratory Journal.

[29]  Elizabeth M. Borycki,et al.  Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease: A Disease-Specific Self-management Intervention , 2003 .

[30]  D. Strachan,et al.  Validity and interpretation of mortality, health service and survey data on COPD and asthma in England , 2003, European Respiratory Journal.

[31]  J. Wedzicha,et al.  Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[32]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[33]  T. Seemungal,et al.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[34]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[35]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[36]  iorgio,et al.  NONINVASIVE VENTILATION FOR ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 2000 .